Live Analyst Rating Changes 28470 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Priyanka Grover
JPM

Priyanka Grover

J.P. Morgan
Wall Street Analyst
★★★☆☆
#1314
on 13Foresight · ranked by our own returns
56%
Success Rate
-0.1%
Average Return
5 of 9 calls profitable · -3.1% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 56% of Priyanka Grover's ratings turned a profit when each position was held for 1 year — averaging -0.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

9 Buy 2 Hold 1 Sell
Priyanka's Stock Coverage 6 ratings · 2026-08-29
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
MREO
Mereo Biopharma Group Plc
 Aug 18, 2026 SELL Strong Buy
+1406.3% avg upside
11 analysts
 — +7.3% ·
NUVB
Nuvation Bio
 Aug 18, 2026 BUY Strong Buy
+97.1% avg upside
17 analysts
$13.00
94.07% Upside
 -0.4% ·
RLAY
Relay Therapeutics
 Aug 14, 2026 BUY Strong Buy
+16.8% avg upside
21 analysts
$31.00
65.02% Upside
 +3.6% ·
BBOT
BridgeBio Oncology Therapeutics
 Aug 14, 2026 BUY Strong Buy
+180.4% avg upside
11 analysts
$25.00
185.69% Upside
 +0.2% ·
RYTM
Rhythm Pharmaceuticals
 Aug 10, 2026 BUY Strong Buy
+14.5% avg upside
21 analysts
$146.00
35.01% Upside
 -3.0% ·
RXRX
Recursion Pharmaceuticals
 Apr 30, 2026 BUY Buy
+134.7% avg upside
12 analysts
$10.00
198.98% Upside
 +0.7% ·
🔒 1 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Priyanka Grover — Frequently Asked Questions
How accurate are Priyanka Grover's stock ratings?
Based on the calls 13Foresight could measure, about 56% of Priyanka's ratings were profitable over a one-year hold, with an average return of -0.1% per rating, or -3.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Priyanka ranked on 13Foresight?
Priyanka Grover is currently ranked #1314 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Priyanka cover?
Priyanka most recently has ratings on MREO, NUVB, RLAY, BBOT, RYTM, RXRX. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.